Novelix Pharmaceuticals Limited (BOM:536565)

Novelix Pharmaceuticals Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Total Valuation

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 10, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Market Capitalization	2,206	1,112	265	139	73	72
Market Cap Growth	262.80%	319.98%	90.16%	91.00%	1.24%	31.51%
Enterprise Value	2,220	1,097	263	114	47	68
Last Close Price	77.50	55.78	26.61	17.19	9.00	8.89

Price Ratios

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 10, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
PE Ratio	51.63	43.49	313.26	1337.29	-	-
PS Ratio	1.50	0.84	0.86	3.07	3.80	0.81
PB Ratio	4.75	2.39	1.51	1.89	1.01	0.94
P/TBV Ratio	4.95	2.50	1.51	1.89	1.01	0.97
P/OCF Ratio	-	-	-	-	-	4.54

EV Ratios

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 10, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
EV/Sales Ratio	1.51	0.83	0.86	2.52	2.46	0.76
EV/EBITDA Ratio	48.45	31.31	160.02	149.01	-	-
EV/EBIT Ratio	49.71	32.24	208.07	297.10	-	-

Financial Efficiency

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 10, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Debt / Equity Ratio	0.09	0.09	-	-	-	0.02
Debt / EBITDA Ratio	0.94	1.23	-	-	-	-
Net Debt / Equity Ratio	0.03	0.03	-0.04	-0.47	-0.44	-0.37
Net Debt / EBITDA Ratio	0.30	0.39	-4.12	-45.61	1401.47	7.08
Net Debt / FCF Ratio	-	-0.05	0.05	10.16	1.31	13.42
Asset Turnover	-	2.21	1.78	0.62	0.24	0.97
Inventory Turnover	-	16.59	50.81	10.24	2.12	10.66
Quick Ratio	-	1.49	1.96	373.65	60.39	4.98
Current Ratio	-	2.14	2.79	407.44	68.83	6.38
Return on Equity (ROE)	-	7.99%	0.68%	0.14%	-0.81%	-26.95%
Return on Assets (ROA)	-	3.56%	0.46%	0.33%	-0.46%	-3.29%
Return on Invested Capital (ROIC)	7.78%	7.90%	0.84%	0.48%	-1.32%	-9.76%
Return on Capital Employed (ROCE)	-	6.70%	0.70%	0.50%	-0.80%	-6.20%

Yields

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 10, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Earnings Yield	1.64%	2.30%	0.32%	0.07%	-0.82%	-28.15%
FCF Yield	-11.62%	-23.06%	-52.09%	-2.47%	-33.05%	-2.94%
Buyback Yield / Dilution	-122.66%	-124.99%	9.80%	-28.54%	-	-

Data Source: S&P Global Market Intelligence Last updated: Aug 13, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 14, 2026

Data Sources Report a data error